LUCANE PHARMA

Serial Number 79115136
Registration 4352108
404

Registration Progress

Application Filed
Jun 5, 2012
Under Examination
Approved for Publication
Apr 2, 2013
Published for Opposition
Apr 2, 2013
Registered
Jun 18, 2013

Basic Information

Serial Number
79115136
Registration Number
4352108
Filing Date
June 5, 2012
Registration Date
June 18, 2013
Published for Opposition
April 2, 2013
Cancellation Date
June 6, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
404
Status Date
Jun 6, 2022

Rights Holder

LUCANE PHARMA

99
Address
172 rue de Charonne
F-75011 PARIS
FR

Ownership History

LUCANE PHARMA

Original Applicant
99
FR

LUCANE PHARMA

Owner at Publication
99
FR

LUCANE PHARMA

Original Registrant
99
FR

Legal Representation

Attorney
Caroline L. Stevens

USPTO Deadlines

Next Deadline
2902 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2013-06-18)
Due Date
June 18, 2033
Grace Period Ends
December 18, 2033

Application History

35 events
Date Code Type Description
Dec 26, 2022 DETH P DEATH OF INTERNATIONAL REGISTRATION
Dec 26, 2022 DENC E NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 12, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Nov 7, 2020 INNT P TOTAL INVALIDATION PROCESSED BY THE IB
Oct 13, 2020 INPC P INVALIDATION PROCESSED
Oct 13, 2020 INTS P TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 24, 2020 INTR P TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 24, 2020 C71T O CANCELLED SECTION 71
Jun 18, 2018 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 15, 2013 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 20, 2013 FIMP P FINAL DISPOSITION PROCESSED
Sep 20, 2013 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Sep 18, 2013 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 18, 2013 R.PR A REGISTERED-PRINCIPAL REGISTER
May 26, 2013 GPNX P NOTIFICATION PROCESSED BY IB
Apr 2, 2013 PUBO A PUBLISHED FOR OPPOSITION
Apr 2, 2013 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 13, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2013 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 13, 2013 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 25, 2013 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 24, 2013 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 31, 2013 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2013 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2013 ALIE A ASSIGNED TO LIE
Jan 22, 2013 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2012 RFNT P REFUSAL PROCESSED BY IB
Sep 24, 2012 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 24, 2012 RFRR P REFUSAL PROCESSED BY MPU
Sep 24, 2012 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 23, 2012 CNRT R NON-FINAL ACTION WRITTEN
Sep 21, 2012 DOCK D ASSIGNED TO EXAMINER
Aug 11, 2012 MAFR O APPLICATION FILING RECEIPT MAILED
Aug 7, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 2, 2012 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"